Robert Kristal - Nov 4, 2021 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Chief Financial Officer
Signature
/s/ Robert Kristal
Stock symbol
BRTX
Transactions as of
Nov 4, 2021
Transactions value $
$0
Form type
4
Date filed
11/16/2021, 03:24 PM
Next filing
Apr 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +10.5K $0.00 10.5K Nov 4, 2021 Common Stock 10.5K $13.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.